Simplex Trading, LLC Bristol Myers Squibb CO Transaction History

Simplex Trading, LLC

  • $3.28 Billion
  • Q4 2024

A detailed history of Simplex Trading, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Simplex Trading, LLC holds 336,628 shares of BMY stock, worth $18.8 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
336,628
Previous 351,086 4.12%
Holding current value
$18.8 Million
Previous $18.2 Million 4.79%
% of portfolio
0.58%
Previous 0.65%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$51.92 - $59.94 $750,659 - $866,612
-14,458 Reduced 4.12%
336,628 $19 Million
Q3 2024

Nov 08, 2024
SELL
$39.66 - $51.75 $8.21 Million - $10.7 Million
-206,925 Reduced 37.08%
351,086 $18.2 Million
Q2 2024

Jul 25, 2024
BUY
$40.25 - $52.99 $2.18 Million - $2.88 Million
54,263 Added 10.77%
558,011 $23.2 Million
Q1 2024

Apr 25, 2024
BUY
$47.98 - $54.4 $24.2 Million - $27.4 Million
503,748 New
503,748 $27.3 Million
Q3 2023

Nov 01, 2023
BUY
$57.89 - $64.73 $5.4 Million - $6.04 Million
93,234 Added 104.34%
182,593 $10.6 Million
Q2 2023

Aug 04, 2023
BUY
$63.71 - $70.74 $5.69 Million - $6.32 Million
89,359 New
89,359 $5.71 Million
Q4 2022

Feb 02, 2023
BUY
$68.48 - $81.09 $1.6 Million - $1.89 Million
23,361 Added 12.45%
210,946 $15.2 Million
Q3 2022

Nov 04, 2022
SELL
$0.13 - $76.84 $6,951 - $4.11 Million
-53,474 Reduced 22.18%
187,585 $13.3 Million
Q2 2022

Aug 03, 2022
BUY
$72.62 - $79.98 $17.5 Million - $19.3 Million
240,884 Added 137648.0%
241,059 $18.6 Million
Q1 2022

May 02, 2022
SELL
$61.48 - $73.72 $10 Million - $12 Million
-162,939 Reduced 99.89%
175 $12,000
Q4 2021

Feb 23, 2022
BUY
$53.63 - $62.52 $3.49 Million - $4.06 Million
65,017 Added 66.28%
163,114 $10.2 Million
Q3 2021

Oct 28, 2021
SELL
$59.17 - $69.31 $4,141 - $4,851
-70 Reduced 0.07%
98,097 $6.53 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $955,085 - $1.04 Million
15,427 Added 18.65%
98,167 $6.56 Million
Q1 2021

Apr 26, 2021
SELL
$59.34 - $66.74 $2.02 Million - $2.27 Million
-33,996 Reduced 29.12%
82,740 $5.22 Million
Q4 2020

Feb 02, 2021
BUY
$57.74 - $65.43 $5.45 Million - $6.18 Million
94,467 Added 424.21%
116,736 $7.24 Million
Q3 2020

Oct 14, 2020
SELL
$57.43 - $63.64 $9.59 Million - $10.6 Million
-167,000 Reduced 88.23%
22,269 $1.34 Million
Q2 2020

Jul 13, 2020
SELL
$54.82 - $64.09 $9.14 Million - $10.7 Million
-166,733 Reduced 46.83%
189,269 $11.1 Million
Q1 2020

Apr 29, 2020
BUY
$46.4 - $67.43 $7.62 Million - $11.1 Million
164,287 Added 85.69%
356,002 $19.8 Million
Q4 2019

Feb 05, 2020
BUY
$49.21 - $64.19 $9.43 Million - $12.3 Million
191,715 New
191,715 $0
Q3 2019

Oct 15, 2019
SELL
$42.77 - $50.71 $8.63 Million - $10.2 Million
-201,734 Closed
0 $0
Q2 2019

Jul 26, 2019
BUY
$44.62 - $49.34 $3.91 Million - $4.32 Million
87,641 Added 76.82%
201,734 $9.15 Million
Q1 2019

Apr 18, 2019
BUY
$45.12 - $53.8 $440,912 - $525,733
9,772 Added 9.37%
114,093 $0
Q4 2018

Jan 16, 2019
BUY
$48.76 - $63.23 $2.05 Million - $2.65 Million
41,956 Added 67.27%
104,321 $5.42 Million
Q3 2018

Oct 23, 2018
SELL
$55.19 - $62.25 $2.21 Million - $2.49 Million
-40,046 Reduced 39.1%
62,365 $3.87 Million
Q2 2018

Jul 30, 2018
SELL
$50.53 - $62.98 $751,229 - $936,323
-14,867 Reduced 12.68%
102,411 $5.67 Million
Q1 2018

Apr 26, 2018
BUY
$59.92 - $68.98 $7.03 Million - $8.09 Million
117,278 New
117,278 $7.42 Million

Others Institutions Holding BMY

# of Institutions
2,749
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email